Scientists call on US to allow research on marijuana for pets
When the federal Drug Enforcement Administration announced last year that even marijuana extracts with CBD and little or no THC – marijuana’s intoxicating component – are an illegal Schedule 1 drug, the University of Pennsylvania halted its clinical trials. Colorado State University is pushing ahead.
The U.S. Food and Drug Administration has warned companies that sell marijuana products online and via pet shops and animal hospitals that they’re violating laws by offering “unapproved new animal drugs.” The FDA threatened legal action.
But, seeing potential benefits of CBDs, the American Veterinary Medical Association’s policy-making body said last summer it wants the DEA to declassify marijuana as a Schedule 1 drug “to facilitate research opportunities for veterinary and human medical uses.” It asked the board of the national veterinarians’ organization to investigate working with other stakeholders toward that goal. The board is awaiting a recommendation from two group councils.
“The concern our membership has is worry about people extrapolating their own dosages, looking to medicate their pets outside the realm of the medical professional,” Board Chairman Michael Whitehair said in a telephone interview. “This is an important reason for us to continue the research.”Cannabist Show: He’s a Humboldt legacy; She promos pot products for pets
- Scientists call on US to allow research on pot meds for petswww.sfgate.comDecember 7, 2017
- Veterinarians Call on DEA to Allow Research on Medical Marijuana for Petswww.civilized.life
- Scientists Call Out Cannabis Industry and Happy to Take the Money - TNMNews.comthenationalmarijuananews.comOctober 25, 2017
- Cannabis: scientists call for action amid mental health concernswww.theguardian.comApril 15, 2016